Oncology & Cancer

Researchers home in on genetic signature of esophageal cancer

University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes.

Oncology & Cancer

Team uncovers pathway linking heartburn and esophageal cancer

Got heartburn? More than 60 million adults in the U.S. have acid reflux, or heartburn, and approximately 10 percent are at risk for developing esophageal cancer, due in part to complications from Barrett's esophagus. But ...

Cardiology

When chest pain isn't a heart attack

Aside from injuries, the second most common reason adults in the United States go to the emergency department is chest pain, accounting for more than 6.5 million visits annually. Despite the growing prevalence of cardiovascular ...

Diseases, Conditions, Syndromes

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Diseases, Conditions, Syndromes

Surgery helps tough-to-treat acid reflux

(HealthDay)—For people with gastroesophageal reflux disease (GERD) that doesn't respond to the usual treatments, a complex surgery may help, a new study finds.

Health

Going gluten-free: Is the diet a good fit for everyone?

(Medical Xpress) -- One of the latest trends in the food market and among celebrities is going gluten-free. Snack giant Frito-Lay has announced it will introduce new gluten-free labels and products, and Miley Cyrus has credited ...

Diseases, Conditions, Syndromes

Sleep disturbance linked to esophageal hypersensitivity

(HealthDay)—For patients with gastroesophageal reflux disease (GERD), sleep disturbance is associated with enhanced heartburn perception to capsaicin infusion, according to a study published online Nov. 29 in the Journal ...

Diseases, Conditions, Syndromes

Risk for COVID-19 increased for adults taking PPIs

(HealthDay)—Adults taking proton pump inhibitors (PPIs) have an increased risk for having a positive COVID-19 test, with evidence of a dose-response relationship, according to a study published online July 7 in preprint ...

page 6 from 19